标题
Pharmacotherapy of alcoholism – an update on approved and off-label medications
作者
关键词
-
出版物
EXPERT OPINION ON PHARMACOTHERAPY
Volume 18, Issue 12, Pages 1187-1199
出版商
Informa UK Limited
发表日期
2017-06-29
DOI
10.1080/14656566.2017.1349098
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Association of plasma calcium concentrations with alcohol craving: New data on potential pathways
- (2017) Rilana Schuster et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The dose-effect relationship of baclofen in alcohol dependence: A 1-year cohort study
- (2017) Baptiste Pignon et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- More Treatments on Deck for Alcohol Use Disorder
- (2017) Jeff Lyon JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The GABAB Positive Allosteric Modulator ADX71441 Attenuates Alcohol Self-Administration and Relapse to Alcohol Seeking in Rats
- (2017) Eric Augier et al. NEUROPSYCHOPHARMACOLOGY
- Metabotropic and ionotropic glutamate receptors as potential targets for the treatment of alcohol use disorder
- (2017) Sunil Goodwani et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Biobehavioral effects of baclofen in anxious alcohol-dependent individuals: a randomized, double-blind, placebo-controlled, laboratory study
- (2017) M Farokhnia et al. Translational Psychiatry
- Drug therapy for alcohol dependence in primary care in the UK: A Clinical Practice Research Datalink study
- (2017) Andrew Thompson et al. PLoS One
- Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers
- (2016) Niamh Fitzgerald et al. ADDICTION
- Harm reduction -a systematic review on effects of alcohol reduction on physical and mental symptoms
- (2016) Katrin Charlet et al. ADDICTION BIOLOGY
- Single-Dose Interaction Study of the Arginine Vasopressin Type 1B Receptor Antagonist ABT-436 and Alcohol in Moderate Alcohol Drinkers
- (2016) David A. Katz et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Serotonin's Complex Role in Alcoholism: Implications for Treatment and Future Research
- (2016) Catherine A. Marcinkiewcz et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Combining Varenicline (Chantix) with Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in a Rodent Model of Alcoholism
- (2016) Janice C. Froehlich et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- The Effect of Varenicline on the Neural Processing of Fearful Faces and the Subjective Effects of Alcohol in Heavy Drinkers
- (2016) Joshua L. Gowin et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Evaluation in alcohol use disorders – insights from the nalmefene experience
- (2016) Florian Naudet et al. BMC Medicine
- Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence
- (2016) Julia M. A. Sinclair et al. DRUG SAFETY
- Nalmefene for the management of alcohol dependence: review on its pharmacology, mechanism of action and meta-analysis on its clinical efficacy
- (2016) Karl Mann et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: A multicentre, randomised, double-blind controlled trial
- (2016) Esther M. Beraha et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Aripiprazole for relapse prevention and craving in alcohol use disorder: current evidence and future perspectives
- (2016) Giovanni Martinotti et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Nalmefene for the treatment of alcohol use disorders: recent data and clinical potential
- (2016) Michael Soyka EXPERT OPINION ON PHARMACOTHERAPY
- Do specific NMDA receptor subunits act as gateways for addictive behaviors?
- (2016) F. W. Hopf GENES BRAIN AND BEHAVIOR
- Anterior Cingulate Glutamate Is Reduced by Acamprosate Treatment in Patients With Alcohol Dependence
- (2016) Mark A. Frye et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Neuroimaging the Effectiveness of Substance Use Disorder Treatments
- (2016) Elizabeth A. Cabrera et al. Journal of Neuroimmune Pharmacology
- Time to connect: bringing social context into addiction neuroscience
- (2016) Markus Heilig et al. NATURE REVIEWS NEUROSCIENCE
- The Neurobiological Mechanisms of Gamma-Hydroxybutyrate Dependence and Withdrawal and Their Clinical Relevance: A Review
- (2016) Rama M. Kamal et al. NEUROPSYCHOBIOLOGY
- Does Acamprosate Really Produce its Anti-Relapse Effects via Calcium? No Support from the PREDICT Study in Human Alcoholics
- (2016) Karl Mann et al. NEUROPSYCHOPHARMACOLOGY
- Low μ-Opioid Receptor Status in Alcohol Dependence Identified by Combined Positron Emission Tomography and Post-Mortem Brain Analysis
- (2016) Derik Hermann et al. NEUROPSYCHOPHARMACOLOGY
- A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence
- (2016) Megan L Ryan et al. NEUROPSYCHOPHARMACOLOGY
- Mirtazapine in comorbid major depression and an alcohol use disorder: A double-blind placebo-controlled pilot trial
- (2016) Jack R. Cornelius et al. PSYCHIATRY RESEARCH
- Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety
- (2016) Raye Z. Litten et al. Substance Abuse
- A Brief Up-Date of the Use of Sodium Oxybate for the Treatment of Alcohol Use Disorder
- (2016) Fabio Caputo et al. International Journal of Environmental Research and Public Health
- The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis
- (2015) Kim Donoghue et al. ADDICTION
- Global statistics on addictive behaviours: 2014 status report
- (2015) Linda R. Gowing et al. ADDICTION
- Variation in the Serotonin Transporter Gene and Alcoholism: Risk and Response to Pharmacotherapy
- (2015) Miles D. Thompson et al. ALCOHOL AND ALCOHOLISM
- Varenicline for Treatment of Alcohol Dependence: A Randomized, Placebo-Controlled Trial
- (2015) Andrea de Bejczy et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- The Role of Gabapentin in the Management of Alcohol Withdrawal and Dependence
- (2015) Jonathan G. Leung et al. ANNALS OF PHARMACOTHERAPY
- High-dose baclofen for the treatment of alcohol dependence (BACLAD study): A randomized, placebo-controlled trial
- (2015) Christian A. Müller et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Moderators of Varenicline Treatment Effects in a Double-Blind, Placebo-Controlled Trial for Alcohol Dependence
- (2015) Daniel E. Falk et al. Journal of Addiction Medicine
- Depression in patients with alcohol use disorders: Systematic review and meta-analysis of outcomes for independent and substance-induced disorders
- (2015) James A. Foulds et al. JOURNAL OF AFFECTIVE DISORDERS
- Zonisamide, Topiramate, and Levetiracetam
- (2015) Clifford M. Knapp et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Serotonergic gene variation in substance use pharmacotherapy: a systematic review
- (2015) Isabelle E Bauer et al. PHARMACOGENOMICS
- Naltrexone vs Placebo for the Treatment of Alcohol Dependence
- (2015) David W. Oslin et al. JAMA Psychiatry
- Epidemiology ofDSM-5Alcohol Use Disorder
- (2015) Bridget F. Grant et al. JAMA Psychiatry
- Posttreatment Effects of Topiramate Treatment for Heavy Drinking
- (2015) Henry R. Kranzler et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Cognitive-Behavioral Treatment With Adult Alcohol and Illicit Drug Users: A Meta-Analysis of Randomized Controlled Trials
- (2015) Molly Magill et al. Journal of Studies on Alcohol and Drugs
- Self-efficacy mediates the effects of topiramate andGRIK1genotype on drinking
- (2014) Henry R. Kranzler et al. ADDICTION BIOLOGY
- A Meta-Analysis of Topiramate's Effects for Individuals with Alcohol Use Disorders
- (2014) Janet C. Blodgett et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Varenicline in the Treatment of Alcohol Use Disorders
- (2014) Beth L. Erwin et al. ANNALS OF PHARMACOTHERAPY
- Acute and chronic administration of a low-dose combination of topiramate and ondansetron reduces ethanol’s reinforcing effects in male alcohol preferring (P) rats.
- (2014) Catherine F. Moore et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- Investigational therapies for the pharmacological treatment of alcoholism
- (2014) Thomas Hillemacher et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Current pharmacological treatment approaches for alcohol dependence
- (2014) Christian A Müller et al. EXPERT OPINION ON PHARMACOTHERAPY
- Topiramate for alcoholism treatment: novel pharmacogenetic evidence for the journey to personalized medicine?
- (2014) Lorenzo Leggio et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Pharmacotherapy for Adults With Alcohol Use Disorders in Outpatient Settings
- (2014) Daniel E. Jonas et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Low-Dose Topiramate in Alcohol Dependence
- (2014) Giovanni Martinotti et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study
- (2014) Wim van den Brink et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The Corticotropin Releasing Hormone-1 (CRH1) Receptor Antagonist Pexacerfont in Alcohol Dependence: A Randomized Controlled Experimental Medicine Study
- (2014) Laura E Kwako et al. NEUROPSYCHOPHARMACOLOGY
- Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis
- (2014) Marilyn D. Skinner et al. PLoS One
- Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals
- (2014) Joseph P. Schacht et al. PSYCHOPHARMACOLOGY
- Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings
- (2014) Lara A. Ray et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- Efficacy of As-Needed Nalmefene in Alcohol-Dependent Patients with at Least a High Drinking Risk Level: Results from a Subgroup Analysis of Two Randomized Controlled 6-Month Studies
- (2013) W. van den Brink et al. ALCOHOL AND ALCOHOLISM
- Determination of Genotype Combinations That Can Predict the Outcome of the Treatment of Alcohol Dependence Using the 5-HT3Antagonist Ondansetron
- (2013) Bankole A. Johnson et al. AMERICAN JOURNAL OF PSYCHIATRY
- GHB receptor targets in the CNS: Focus on high-affinity binding sites
- (2013) Tina Bay et al. BIOCHEMICAL PHARMACOLOGY
- Results from a pilot clinical trial of varenicline for the treatment of alcohol dependence
- (2013) Jennifer G. Plebani et al. DRUG AND ALCOHOL DEPENDENCE
- A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence
- (2013) Antoni Gual et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- A Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Varenicline Tartrate for Alcohol Dependence
- (2013) Raye Z. Litten et al. Journal of Addiction Medicine
- Antipsychotics for Primary Alcohol Dependence
- (2013) Taro Kishi et al. JOURNAL OF CLINICAL PSYCHIATRY
- Varenicline Treatment of Concurrent Alcohol and Nicotine Dependence in Schizophrenia
- (2013) Zsuzsa Szombathyne Meszaros et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- The role of the opioid system in alcohol dependence
- (2013) David J Nutt JOURNAL OF PSYCHOPHARMACOLOGY
- Acamprosate Produces Its Anti-Relapse Effects Via Calcium
- (2013) Rainer Spanagel et al. NEUROPSYCHOPHARMACOLOGY
- Gabapentin Treatment for Alcohol Dependence
- (2013) Barbara J. Mason et al. JAMA Internal Medicine
- Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?
- (2012) Natalya C. Maisel et al. ADDICTION
- Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study
- (2012) Karl Mann et al. ADDICTION BIOLOGY
- Reward and relief craving tendencies in patients with alcohol use disorders: Results from the PREDICT study
- (2012) Angelika Glöckner-Rist et al. ADDICTIVE BEHAVIORS
- Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependence
- (2012) Brendan M. Walker et al. ALCOHOL
- Varenicline Potentiates Alcohol-Induced Negative Subjective Responses and Offsets Impaired Eye Movements
- (2012) Emma Childs et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Extending the Treatment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed Nalmefene
- (2012) Karl Mann et al. BIOLOGICAL PSYCHIATRY
- Functional Polymorphism of the Dopamine β-Hydroxylase Gene Is Associated With Increased Risk of Disulfiram-Induced Adverse Effects in Alcohol-Dependent Patients
- (2012) Jochen Mutschler et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Varenicline decreases alcohol consumption in heavy-drinking smokers
- (2012) Jennifer M. Mitchell et al. PSYCHOPHARMACOLOGY
- Pharmacogenetic Approach at the Serotonin Transporter Gene as a Method of Reducing the Severity of Alcohol Drinking
- (2011) Bankole A. Johnson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Antidepressants for Major Depressive Disorder and Dysthymic Disorder in Patients With Comorbid Alcohol Use Disorders
- (2011) Nadia Iovieno et al. JOURNAL OF CLINICAL PSYCHIATRY
- Substitution therapy for alcoholism: time for a reappraisal?
- (2011) Jonathan Chick et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Severity of drinking as a predictor of efficacy of the combination of ondansetron and topiramate in rat models of ethanol consumption and relapse
- (2011) Wendy J. Lynch et al. PSYCHOPHARMACOLOGY
- A preliminary investigation of varenicline for heavy drinking smokers
- (2011) Lisa M. Fucito et al. PSYCHOPHARMACOLOGY
- Systemic κ-opioid receptor antagonism by nor-binaltorphimine reduces dependence-induced excessive alcohol self-administration in rats
- (2010) Brendan M. Walker et al. ADDICTION BIOLOGY
- A double-blind, placebo-controlled, randomized pilot study comparing quetiapine with placebo, associated to naltrexone, in the treatment of alcohol-dependent patients
- (2010) Josep Guardia et al. ADDICTIVE BEHAVIORS
- Efficacy and Safety of Baclofen for Alcohol Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2010) James C. Garbutt et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Dose-dependent and sustained effects of varenicline on dopamine D2/3 receptor availability in rats
- (2010) Cleo L. Crunelle et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Reciprocal responsiveness of nucleus accumbens shell and core dopamine to food- and drug-conditioned stimuli
- (2010) Valentina Bassareo et al. PSYCHOPHARMACOLOGY
- Effect of Acute Ethanol Administration on the Release of Opioid Peptides From the Midbrain Including the Ventral Tegmental Area
- (2009) Samuel Jarjour et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Varenicline Reduces Alcohol Self-Administration in Heavy-Drinking Smokers
- (2009) Sherry A. McKee et al. BIOLOGICAL PSYCHIATRY
- The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: A review
- (2009) Cleo L. Crunelle et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- A preliminary pharmacogenetic investigation of adverse events from topiramate in heavy drinkers.
- (2009) Lara A. Ray et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Aripiprazole for the Treatment of Alcohol Dependence
- (2009) Raymond F. Anton et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Efficacy of a Combination of Flumazenil and Gabapentin in the Treatment of Alcohol Dependence
- (2009) Raymond F. Anton et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Alcoholism: A Systems Approach From Molecular Physiology to Addictive Behavior
- (2009) Rainer Spanagel PHYSIOLOGICAL REVIEWS
- Genetic basis for predicting response to naltrexone in the treatment of alcohol dependence
- (2008) Raymond F Anton PHARMACOGENOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started